Generic Drug Therapeutic Class: Neurology-Psychiatry
active ingredients: Betahistine
laboratory: Accord Healthcare France
Box of 30
Betahistine is indicated for the treatment of Meniere's syndrome, which may include dizziness, tinnitus, hearing loss and nausea.
Dosage BETAHISTINE ACCORD 8 mg Tablet Box of 30
The initial treatment is 8 to 16 mg three times a day orally, preferably taken at mealtimes.
Maintenance doses are usually between 24 and 48 mg per day. The daily dose should not exceed 48 mg. The dosage can be adjusted to meet the particular needs of each patient. An improvement can sometimes be seen after 2 or 3 weeks of treatment.
No data is available for patients with hepatic impairment.
No data is available for patients with renal impairment.
The data available in the elderly are limited, so betahistine should be used with caution in these patients.
BETAHISTINE ACCORD is not recommended in children and adolescents under 18 years of age due to a lack of safety and efficacy data for this patient population.
Betahistine is contraindicated in patients with pheochromocytoma. Since betahistine is a synthetic analogue of histamine, it can induce the release of catecholamines by the tumor, resulting in severe hypertension.
Hypersensitivity to the active substance or to any of the excipients.
Adverse effects Betahistine Accord
Within each frequency group, adverse effects are presented in descending order of severity.
Immune system disorders
Very rare (<1 / 10, 000): rash and pruritus.
Nervous system disorders
Frequency not known: headache and occasional drowsiness.
Rare (> 1/10 000 and <1/1000): gastrointestinal disturbances, nausea and dyspepsia.
Rare (> 1/10 000 and <1/1000): palpitations.
Skin and subcutaneous tissue disorders
Rare (> 1/10 000 and <1/1000): urticaria.